Mumbai: EQT Companions is seeking to elevate almost $1 billion (₹8,996 crore) by promoting its complete 40% stake in CitiusTech, a worldwide healthcare expertise, analytics and consulting firm, monetising its six-year-old funding, stated folks conscious of the matter.
The Swedish buyout group is working with advisors to achieve out to potential non-public fairness suitors, the folks stated. The stake sale may worth the corporate at $2.2-$2.4 billion or 18-20x of its FY26 Ebitda of round $120 million, they stated.
EQT’s plans come at a time when CitiusTech is seeing a gradual uptick in development momentum after almost two years of muted gross sales as a consequence of lowered expertise budgets globally.
Based by serial tech entrepreneur Rizwan Koita and his fellow IIT alumnus Jagdish Moorjani, CitiusTech is owned 40% every by EQT (previously Baring Non-public Fairness Asia) and Bain Capital. The remaining stake is held by the founders and staff.
Bain purchased half of EQT’s 80% holding in 2022 for about $960 million in a intently fought bidding warfare with Fujitsu of Japan and Apax Companions.
Nevertheless, EQT could at the moment discover it troublesome to earn a major premium from the Bain spherical and is more likely to perform the proposed deal on the identical valuation, stated the folks cited above. Different shareholders are additionally unlikely to money out instantly except strategic pursuits see a major valuation soar.
EQT first invested in CitiusTech in 2019, buying about 80% from the founders and Normal Atlantic (GA), valuing the corporate at somewhat over $1 billion. GA, the primary massive institutional investor within the firm, had deployed $111 million in 2014.
“EQT has already recovered its capital investments with good-looking returns from their partial stake sale to Bain,” stated a tech sector analyst aware of the corporate’s enterprise efficiency. “The valuation doubled in simply three years. However with macro headwinds and cuts throughout IT spends worldwide, the margins within the enterprise have shrunk since 2022. The expansion momentum although, is coming again.”
EQT didn’t reply to ET’s queries.
CitiusTech is among the world’s main healthcare IT and digital consulting corporations. With a workforce of greater than 7,500 healthcare tech professionals, the corporate helps over 140 shoppers, together with main well being insurers, hospitals, and medical expertise and life sciences corporations. It earns about 95% of its revenues from the US although it has been making an attempt to diversify its footprint in Europe and Japan
CitiusTech is among the world’s main healthcare IT and digital consulting corporations. With a workforce of greater than 7,500 healthcare tech professionals, the corporate helps over 140 shoppers, together with main well being insurers, hospitals, and medical expertise and life sciences corporations. It earns about 95% of its revenues from the US although it has been making an attempt to diversify its footprint in Europe and Japan
CitiusTech counts DaVita, MultiPlan, Centra Well being, Watson Well being Imaging, Very important Pictures, NantHealth, Novant Well being, Kern Well being Programs and Santa Clara Household Well being Plan, amongst its main shoppers.
Its core capabilities span healthcare interoperability, safe information administration, analytics, affected person expertise options, value-based care, medical imaging, linked well being, care coordination, and inhabitants well being administration.
To strengthen its world footprint, CitiusTech has made a number of acquisitions lately. In August, it acquired Well being Knowledge Movers, a US-based agency with deep experience in Epic Programs, Workday, ServiceNow, and different healthcare platforms. Earlier buys embrace Wilco Supply, a Salesforce health-cloud specialist, and SDLC Companions, which serves main US payer organisations.
A few of these acquisitions confronted challenges for the businesses after key shoppers departed following their buyouts, prompting Citius Tech to vary its CEO and appoint Rajan Kohli, a former Wipro veteran in 2023. CitiusTech competes with world healthcare and health-IT gamers akin to RED.Well being, Falck, NNIT, AMN Healthcare, Alira Well being, Nordic, and Surgical procedure Companions, in keeping with Tracxn.
There have been experiences that the corporate will consider an IPO this yr, both within the US or India.
The corporate had beforehand said a goal of $1 billion in income by FY28, which it’s assured of reaching. Kohli had stated in earlier media interactions that it’s anticipating mid-teens income development in FY26, after excessive single-digit income development in FY25.
“Being a specialised participant in healthcare has helped the corporate rebound as demand for healthcare expertise providers is seeing a comeback amongst medtech, healthcare, and life sciences corporations,” stated the CEO of a rival firm. “However for the previous two years, enterprise has been flat. Between FY23-26, Ebitda development in my assumption can be 5-7% in absolute phrases.”
Following the Hello-Tech Act in 2010 that pressured US medical information to get digitised, a worldwide pattern throughout Europe and pockets of Asia has thrown open new enterprise alternatives for tech suppliers. The whole healthcare spending within the US is projected to surge to $6.2 trillion by 2028 from $4.7 trillion in 2023. Inside this, spending on inpatient and outpatient care spending is predicted to rise to $3.5 trillion from $2.7 trillion.
